	PEOPLE	CENTERS	COMMUNITIES	RESEARCH STORIES

R01: TARGETING OF DOPPEL-AXIS TO CONTROL LUNG TUMOR ANGIOGENESIS AND IMMUNITY

R01: TARGETING OF DOPPEL-AXIS TO CONTROL LUNG TUMOR ANGIOGENESIS AND IMMUNITY

PI: Taslim Al-Hilal

Sponsor: NIH - NATIONAL CANCER INSTITUTE

Pharmaceutical Sciences

Amount awarded: $1,745,584

This research explores whether the protein, doppel, arrests growth of blood vessels in tumors, thus, eliminating tumor growth and reducing off-tumor effects.

Posting date: Sun, 07/31/2022

Award start date: Mon, 08/01/2022

Award end date: Sat, 07/31/2027

© 2013 The University of Texas at El Paso | Terms Of Use | Privacy Statement | Questions or Comments about this site? Click here

Some of the content on this web site includes information taken from UTEP's Faculty Success (formerly Digital Measures) and Marketing and Communications.
This material is based upon work supported in part by the Research & Innovation and the National Science Foundation under Grant No. DUE-0963648 and CREST Grant No. HRD-1242122. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation (NSF).